MedPath

A prospective study to examine the expression status of circulating tumor DNA in patients with high-risk early breast cancer and its association with metastasis and recurrence

Not Applicable
Conditions
Breast Cancer
Registration Number
JPRN-UMIN000050208
Lead Sponsor
Kyoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1 More than 6 months have passed since the completion of radical treatment 2 Having multiple cancers (excludes carcinoma in situ of the skin other than malignant melanoma) 3. Pregnancy, history of organ transplantation, or other conditions that affect ctDNA analysis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath